Coloma Jason V has filed 5 insider transactions across 1 company since September 2025.
Most recent transaction: a sale of 1822 shares of Maze Therapeutics, Inc. ($MAZE) on May 15, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Maze Therapeutics, Inc. | $MAZE | Coloma Jason V | Chief Executive Officer | S | Common Stock | 1822 | $26.00 | 412,074.0000 | 48,119,444 | 0.44% | 0.00% |
| May 15, 2026 | Maze Therapeutics, Inc. | $MAZE | Coloma Jason V | Chief Executive Officer | S | Common Stock | 116 | $26.00 | 412,074.0000 | 48,119,444 | 0.03% | 0.00% |
| March 2, 2026 | Maze Therapeutics, Inc. | $MAZE | Coloma Jason V | Chief Executive Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 48,119,444 | 9999.99% | 0.31% |
| March 2, 2026 | Maze Therapeutics, Inc. | $MAZE | Coloma Jason V | Chief Executive Officer | A | Restricted Stock Units | 75000 | $0.00 | 75,000.0000 | 48,119,444 | 9999.99% | 0.16% |
| Sept. 22, 2025 | Maze Therapeutics, Inc. | $MAZE | Coloma Jason V | Chief Executive Officer | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |